Pharmaceutical Technology

NOVEMBER 7, 2022

Out of the total job titles, the top five roles commanded a 95.48% share in the overall IT recruitment activity of the UK’s pharma industry in October 2022. Top five pharma companies in the UK’s IT recruitment activity in October 2022. Junior Level job postings dominate in October 2022.

Genome 130

Genome Genomics Pharma Companies Development 130

Camargo

NOVEMBER 11, 2020

In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharma companies’ therapeutics. Approval of the Month: Companion Diagnostic for Bayer’s Vitrakvi Should Lead to Improved Patient Outcomes.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genomics Genome 59

pharmaphorum

JANUARY 24, 2022

” Watson Health offers a range of other services of course, including tools for genomic analysis and running clinical trials that have found favour with a number of pharma companies.

Radiology 111

Radiology Marketing Genome Genomics 111

pharmaphorum

OCTOBER 12, 2022

Those will be combined with AZ’s analysis framework for rare variant genomic discoveries, as well as the drugmaker’s own AI tools, including JARVIS – a tool which focuses on non-coding or ‘junk’ regions of the genome.

Genome 64

Genome Genomics DNA Drugs 64

pharmaphorum

OCTOBER 20, 2021

The trial – which will be supported by pharma company Eisai and Ionian University in the US – will see if the test can identify people who have mild cognitive impairment (MCI) due to Alzheimer’s disease. ” The post Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s appeared first on.

Trials 78

Trials Genome Genomics Bioinformatics 78

pharmaphorum

JANUARY 24, 2023

The cost of testing per human genome in 2006 was approximately $14 million , and in less than two decades, an average consumer-purchased genetic test costs $100. The same is becoming true for the healthcare industry, and one of the first major breakthroughs in the area was the 100,000 Genomes Project.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

pharmaphorum

NOVEMBER 19, 2020

The latest crop of recipients in the G4A scheme were selected from more than 400 applications from companies in dozens of countries around the world and have apps covering women’s health, chronic conditions, genomic testing, disease management and telemedicine.

Genome 64

Genome Genomics Nurses Pharma Companies 64

pharmaphorum

OCTOBER 18, 2022

US-based Tempus has built a precision medicine platform – powered by artificial intelligence and machine learning – that sifts through a large library of anonymised patient data, including results of clinical, molecular, and genomic testing.

Production 52

Production Clinical Trials Clinical Trials Genome 52

XTalks

DECEMBER 20, 2023

In 2024, pharma companies and emerging biotechs will improve candidate safety profiles and reduce off-target effects by exploiting predictive intelligence unlocked by AI,” she predicts. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Pharma Marketing Network

OCTOBER 17, 2024

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Marketing 52

Marketing Pharma Companies Regulation Production 52

XTalks

OCTOBER 8, 2020

A fresh or renewed start can be effectively facilitated with a corporate name change to reflect certain changes in a company’s values, missions and interests. As another recent example, genomics data company Wuxi NextCODE underwent restructuring and has emerged under the new name Genuity Science. NYSE/TSX: BHC) in 2018.

Manufacturing 98

Manufacturing Life Science Cosmetics Regulation 98

pharmaphorum

NOVEMBER 12, 2020

The mid-sized pharma group has also signed a collaboration with Florida, US-based Lacerta Therapeutics , adding more AAV capsids – well established as a staple for delivering gene therapy sequences – as well as another gene therapy candidate.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52

pharmaphorum

DECEMBER 9, 2022

The PharmaStars accelerator was set up last year to help bridge the gap between digital health start-ups and potential pharma partners, which can be instrumental in making sure their technologies meet their potential – and help them to navigate the challenges of developing them in the highly regulated healthcare environment.

Life Science 52

Life Science DNA Genome Genomics 52

Pharma Marketing Network

OCTOBER 24, 2024

Websites, mobile apps, and digital ads are more than just tools—they are lifelines connecting pharma companies to healthcare professionals and patients. The Rise of Personalized Medicine Pharma marketing isn’t just about mass-market medications anymore; it’s about tailoring treatments.

Marketing 52

Marketing Branding Pharma Companies Compliance 52

pharmaphorum

MAY 18, 2022

In the UK, research organisations and pharma companies are working to find ways to reach this goal, using data to inform commercial clinical research now, and how this foundation can be built upon in the future. Historically, site selection was often influenced by experience and relationships between pharma companies and researchers.

Research 81

Research Clinical Research Trials Pharma Companies 81

XTalks

AUGUST 27, 2020

The company’s lead adenoviral vector-based vaccine candidate, Ad26.COV2.S, Johnson & Johnson began work on the vaccine in January 2020, as soon as the genomic sequence for SARS-CoV-2 — the coronavirus that causes COVID-19 — was made available. S, was developed using Janssen’s proprietary AdVac technology.

Vaccine 52

Vaccine Vaccination Trials Clinical Trials 52

Pharma Marketing Network

OCTOBER 14, 2024

These technologies enable pharmaceutical companies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Content marketing is another powerful tool in the pharma marketer’s arsenal.

Marketing 52

Marketing Branding Big Data Drugs 52

Pharmaceutical Technology

FEBRUARY 13, 2023

With the latest advances in whole genome sequencing , it is increasingly clear that rare epilepsies are largely caused by a single genomic mutation, says Ferraro. New developments in the anti-seizure pipeline Genomic screenings can also be used to sharpen the efficacy of already available treatments.

Research 264

Research Gene Gene Therapy Genome 264

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. The genomic medicine journey.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

DECEMBER 6, 2022

A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. In 2018, the 100,000 Genomes Project completed its collection of data from 100,000 participants and the study of that collected information is still on-going.

Genome Project 98

Genome Project Research Genome Genomics 98

Pharmaceutical Technology

MARCH 20, 2023

Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. One significant growth area is the rise of genomics. Further rate hikes could be on the way this year.

Gene Therapy 225

Gene Therapy Genome Genomics Gene 225

pharmaphorum

AUGUST 10, 2020

The data mining tool will be used to try to unearth some of the many unknowns with the virus, using next-generation sequencing (NGS) to see how the genome of SARS-CoV-2 changes over time, along with patient genetic information, results of lung and CT scans, and other clinical data.

Genetics 136

Genetics Genome Genomics Vaccine 136

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. This is significant because shortages of RNA extraction kits have been a recurrent issue since the beginning of the pandemic.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

pharmaphorum

APRIL 19, 2021

But it has also faced criticism from pharma companies that say it undervalues medicines – patients in the country were denied access to the expensive cystic fibrosis drug Orkambi for four years because of a pricing row with NICE and the NHS.

Medicine 88

Medicine Pharma Companies Genome Genomics 88

pharmaphorum

MARCH 30, 2021

Alexion is a somewhat unique pharma company in that it focuses almost entirely on rare diseases – and although this is an immensely challenging area to operate in, the company’s senior vice president of its international business, Camilla Harder Hartvig, says it provides an unparalleled “sense of mission”.

Genetics 111

Genetics Marketing Development Genomics 111

pharmaphorum

OCTOBER 28, 2020

That narrative, for many patients, is that pharma companies just don’t care”. Pharma is swimming against the tide and can’t pretend that the democratisation of medicines data doesn’t exist — because it’s already here. 72% do not feel listened to by pharmaceutical companies. Yet it is widely mistrusted.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

SEPTEMBER 7, 2022

For example, currently, most genomics studies are conducted in populations of European descent, whilst African ancestry populations, for example, show significantly greater genetic variation. The same is true for Asian and Hispanic populations.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Genetics 98

pharmaphorum

AUGUST 9, 2022

The potential of the area has motivated an increasing number of companies to emerge in the space, with a greater number of collaborations occurring between these AI-specialists and big pharma companies. Patient focus.

Drugs 111

Drugs Doctors Doctor Pharma Companies 111

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

APRIL 7, 2022

” Now, the aim is to layer in genomics surveillance using Ares’ next-generation sequencing (NGS) expertise, improving the monitoring of resistant pathogens and making sure that antibiotics are prescribed wisely. “AMR, which is now estimated to directly account for nearly 1.3

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

pharmaphorum

OCTOBER 5, 2021

The next level is to make medical data available for research purposes through digital platforms, such as through the work of our portfolio company BC Platforms , who integrate clinical and genomic data of millions of patients globally. We need the whole value chain to come together and transform how healthcare works.

Doctors 132

Doctors Doctor Marketing Development 132

Delveinsight

DECEMBER 15, 2020

Gannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-alcoholic steatohepatitis (NASH). The FTA designation will help the pharma company to advance its research and development in the NASH landscape and help its commercialization in the market.

Vaccine 54

Vaccine Vaccination Gene Therapy Gene 54

The Pharma Data

OCTOBER 14, 2020

ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., The patent is valid through 2038. Ltd of Japan. Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

Roots Analysis

JULY 31, 2024

However, owing to the subtle differences in genomic makeup of individual patients, these biomarkers alone have been shown to be insufficient in determining how patients are likely to respond to various drug / therapy types. Further, majority of these companies are headquartered in North America (~70%) followed by Europe and Asia-Pacific.

Marketing 40

Marketing Genome Genomics Clinical Trials 40

XTalks

DECEMBER 13, 2023

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

DECEMBER 15, 2022

With the bell then tolling within the House of Commons, Brine concluded that prevention and care were critical, and particularly future cancer care – getting ‘upstream’ of symptom-led early diagnosis with genomic medicine, despite the ‘billion ethical questions’ that go alongside that. Sharing knowledge and best practice.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97